Intermittent Phototherapy vs Continuous Phototherapy in Treating Neonatal Jaundice - A Randomized Controlled Trial

Not Applicable

Conditions: Reproductive Health and Childbirth - Childbirth and postnatal care
eonatal Jaundice
Neonatal Jaundice
Reproductive Health and Childbirth - Complications of newborn
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation

Registration Number: ACTRN12624000860561

Lead Sponsor: niversiti Sains Malaysia

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot yet recruiting

Sex: All

Target Recruitment: 74

Inclusion Criteria

1. Bilirubin level must be within 50umol/L from phototherapy level based on age
2. Age must be more than 24 hours but less than 2 weeks of life
3. Gestational age more than 38 weeks
4. Birth weight more than 2.5kg
5. Low risk based on Malaysia Paediatric Protocol in which subjects do not have the following risk factors : ABO incompatibility, Glucose-6-phosphate dehydrogenase (G6PD) deficiency, clinical sepsis, Rhesus isoimmunization, asphyxia

Exclusion Criteria

1. severe jaundice required intensive phototherapy
2. syndromic babies
3. had risk factos such as ABO incompatibility, G6PD deficiency, clinical sepsis, Rhesus isoimmunization, asphyxia

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of decline of bilirubin per hour in each group [serum bilirubin level Baseline bilirubin level before starting phototherapy and at 24 hours post baseline bilirubin level]

Secondary Outcome Measures

Name	Time	Method
compare the mean of serum bilirubin post 24 hours phototherapy [Serum bilirubin 24 hours serum bilirubin post baseline];compare the rate of treatment failure in each group[serum bilirubin serum bilirubin at 24 hours post baseline will be used to decide to continue or stop the phototherapy. Require another phototherapy will be consider as treatment failure ]